Lexeo Therapeutics, Inc. (LXEO) Tops Q2 EPS by 46c
Tweet
Share
E-mailGet Alerts LXEO Hot Sheet
Join SI Premium – FREE
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q2 EPS of ($0.30), $0.46 better than the analyst estimate of ($0.76).
For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Marchex (MCHX) Reports In-Line Q2 EPS
- ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
